Multi-centre randomised trial of invasive and less invasive surfactant delivery methods showed similar spirometry results at 5-9 years of age.
endotracheal intubation
forced expiratory volume
less invasive surfactant administration
preterm infant
Journal
Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
revised:
23
07
2022
received:
05
04
2022
accepted:
26
07
2022
pubmed:
28
7
2022
medline:
12
10
2022
entrez:
27
7
2022
Statut:
ppublish
Résumé
We explored whether subnormal forced expiratory volume within 1 s (FEV The multi-centre, randomised Nonintubated Surfactant Application trial enrolled 211 preterm infants born at 23-26 weeks of gestation from 13 level III neonatal intensive care units from April 2009 to March 2012. They received surfactant via LISA (n = 107) or after conventional endotracheal intubation (n = 104). The follow-up assessments were carried out by a single team blinded to the group assignments. The main outcome was FEV Spirometry was successful in 102/121 children. The other children died or were lost to follow-up. Median FEV The proportion of children aged 5-9 years with subnormal FEV
Substances chimiques
Pulmonary Surfactants
0
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
2108-2114Subventions
Organisme : Bundesministerium f uuml;r Bildung und Forschung
ID : 01ER0805
Organisme : Bundesministerium f uuml;r Bildung und Forschung
ID : 01ER1501
Organisme : Chiesi Farmaceutici
Organisme : Federal Ministry of Education and Research
Organisme : Chiesi
Informations de copyright
© 2022 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
Références
Herting E, Härtel C, Göpel W. Less invasive surfactant administration (LISA): chances and limitations. Arch Dis Child Fetal Neonatal ed. 2019;104(6):F655-F659. doi:10.1136/archdischild-2018-316557
Göpel W, Kribs A, Ziegler A, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011;378(9803):1627-1634. doi:10.1016/S0140-6736(11)60986-0
Kribs A, Roll C, Göpel W, et al. Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial. JAMA Pediatr. 2015;169(8):723-730. doi:10.1001/jamapediatrics.2015.0504
Isayama T, Iwami H, McDonald S, Beyene J. Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants: a systematic review and meta-analysis. Jama. 2016;316(6):611-624. doi:10.1001/jama.2016.10708
Abdel-Latif ME, Davis PG, Wheeler KI, De Paoli AG, Dargaville PA. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2021;5(5):CD011672. doi:10.1002/14651858.CD011672.pub2
Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the Management of Respiratory Distress Syndrome - 2019 update. Neonatology. 2019;115(4):432-450. doi:10.1159/000499361
Herting E, Kribs A, Härtel C, et al. Two-year outcome data suggest that less invasive surfactant administration (LISA) is safe. Results from the follow-up of the randomized controlled AMV (avoid mechanical ventilation) study. Eur J Pediatr. 2020;179(8):1309-1313. doi:10.1007/s00431-020-03572-0
Mehler K, Broer A, Roll C, et al. Developmental outcome of extremely preterm infants is improved after less invasive surfactant application: developmental outcome after LISA. Acta Paediatr. 2021;110(3):818-825. doi:10.1111/apa.15565
Zapletal A, Chalupová J. Forced expiratory parameters in healthy preschool children (3-6 years of age). Pediatr Pulmonol. 2003;35(3):200-207. doi:10.1002/ppul.10265
Quanjer PH, Stanojevic S, Cole TJ, et al. ERS global lung function initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324-1343. doi:10.1183/09031936.00080312
Zivanovic S, Peacock J, Alcazar-Paris M, et al. Late outcomes of a randomized trial of high-frequency oscillation in neonates. N Engl J Med. 2014;370(12):1121-1130. doi:10.1056/NEJMoa1309220
Harris C, Bisquera A, Lunt A, Peacock JL, Greenough A. Outcomes of the neonatal trial of high-frequency oscillation at 16 to 19 years. N Engl J Med. 2020;383(7):689-691. doi:10.1056/NEJMc2008677
Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357(19):1946-1955. doi:10.1056/NEJMra067279
Rao JN, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics. 1992;48(2):577-585.
Taylor-Cousar JL, Munck A, McKone EF, et al. Tezacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del. N Engl J Med. 2017;377(21):2013-2023. doi:10.1056/NEJMoa1709846
Steinhorn R, Davis JM, Göpel W, et al. Chronic pulmonary insufficiency of prematurity: developing optimal endpoints for drug development. J Pediatr. 2017;191:15-21.e1. doi:10.1016/j.jpeds.2017.08.006
Mehler K, Grimme J, Abele J, Huenseler C, Roth B, Kribs A. Outcome of extremely low gestational age newborns after introduction of a revised protocol to assist preterm infants in their transition to extrauterine life. Acta Paediatr. 2012;101(12):1232-1239. doi:10.1111/apa.12015
Teig N, Weitkämper A, Rothermel J, et al. Observational Study on Less Invasive Surfactant Administration (LISA) in preterm infants <29 weeks - short and long-term outcomes. Z Geburtshilfe Neonatol. 2015;219(6):266-273. doi:10.1055/s-0035-1547295
Márquez Isidro E, Sánchez Luna M, Ramos-Navarro C. Long-term outcomes of preterm infants treated with less invasive surfactant technique (LISA). J Matern Fetal Neonatal Med. 2021;34(12):1919-1924. doi:10.1080/14767058.2019.1651276
Porath M, Korp L, Wendrich D, Dlugay V, Roth B, Kribs A. Surfactant in spontaneous breathing with nCPAP: neurodevelopmental outcome at early school age of infants ≤27 weeks. Acta Paediatr. 2011;100(3):352-359. doi:10.1111/j.1651-2227.2010.02068.x
Thunqvist P, Tufvesson E, Bjermer L, et al. Lung function after extremely preterm birth-a population-based cohort study (EXPRESS). Pediatr Pulmonol. 2018;53(1):64-72. doi:10.1002/ppul.23919
Serenius F, Ewald U, Farooqi A, et al. Extremely preterm infants in Sweden study group. Neurodevelopmental outcomes among extremely preterm infants 6.5 years after active perinatal Care in Sweden. JAMA Pediatr. 2016;170(10):954-963. doi:10.1001/jamapediatrics.2016.1210
Dargaville PA, Kamlin COF, Orsini F, et al. Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: the OPTIMIST-A randomized clinical trial. Jama. 2021;326(24):2478-2487. doi:10.1001/jama.2021.21892